Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

Clinical study shows drug has COVID-19 treatment potential

Interim data reportedly indicates Noxopharm’s Veyonda could be effective in treating cytokine storm, an inflammatory effect associated with moderate cases.

Could synthetic solutions fix supply chain challenges?

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.

Content provided by PharmaNutra Spa

Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement

An investigation was recently conducted in Italy on around 200 post-Covid patients suffering from persistent fatigue, who were advised to take Apportal for 28 days

Getting cancer trials back on track after COVID-19

A leader from oncology trial insights and analysis specialist Inteliquet discusses how cancer studies can recover after the impact of the global pandemic.

Industry veteran suggests solutions to strengthen clinical care

In this second part of a series on the state of clinical research, a leader from Javara lays out ideas to bring clinical research and care closer together.

Content provided by FedEx

Building resilient healthcare supply chains post-pandemic

COVID-19 drastically reconfigured APAC healthcare supply chains in the past year. So what’s next?

Veeva, Parexel forge partnership to accelerate trials

The trial technology provider and contract research organization will collaborate on tech and process solutions designed to accelerate clinical studies.